These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34741331)

  • 1. Letter: cross-linkage between bacterial taxonomy and gene functions-a study of metagenome-assembled genomes of gut microbiota in adult non-alcoholic fatty liver disease.
    Han W; Hou J
    Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1505-1507. PubMed ID: 34741331
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-linkage between bacterial taxonomy and gene functions: a study of metagenome-assembled genomes of gut microbiota in adult non-alcoholic fatty liver disease.
    Canivet CM; David N; Pailhoriès H; Briand M; Guy CD; Bouchez O; Hunault G; Fizanne L; Lannes A; Oberti F; Fouchard I; Calès P; Diehl AM; Barret M; Boursier J
    Aliment Pharmacol Ther; 2021 Mar; 53(6):722-732. PubMed ID: 33482026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: metagenome-assembled genomes in non-alcoholic fatty liver disease.
    Chan WK; Wong VW
    Aliment Pharmacol Ther; 2021 Mar; 53(6):755-756. PubMed ID: 33599321
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current status of gut microbiota and metagenome with nonalcoholic fatty liver disease].
    Shen F; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):811-4. PubMed ID: 24516926
    [No Abstract]   [Full Text] [Related]  

  • 5. Astaxanthin Prevents Alcoholic Fatty Liver Disease by Modulating Mouse Gut Microbiota.
    Liu H; Liu M; Fu X; Zhang Z; Zhu L; Zheng X; Liu J
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30217037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan.
    Tsai MC; Liu YY; Lin CC; Wang CC; Wu YJ; Yong CC; Chen KD; Chuah SK; Yao CC; Huang PY; Chen CH; Hu TH; Chen CL
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32204538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time?
    Demir M; Lang S; Martin A; Farowski F; Wisplinghoff H; Vehreschild MJGT; Krawczyk M; Nowag A; Scholz CJ; Kretzschmar A; Roderburg C; Lammert F; Goeser T; Kasper P; Steffen HM
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1969-1977. PubMed ID: 32267559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency.
    Spencer MD; Hamp TJ; Reid RW; Fischer LM; Zeisel SH; Fodor AA
    Gastroenterology; 2011 Mar; 140(3):976-86. PubMed ID: 21129376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of the Gut Microbiome in Hypertension.
    Yan Q; Gu Y; Li X; Yang W; Jia L; Chen C; Han X; Huang Y; Zhao L; Li P; Fang Z; Zhou J; Guan X; Ding Y; Wang S; Khan M; Xin Y; Li S; Ma Y
    Front Cell Infect Microbiol; 2017; 7():381. PubMed ID: 28884091
    [No Abstract]   [Full Text] [Related]  

  • 10. Genomic Expansions in the Human Gut Microbiome.
    Moeller AH
    Genome Biol Evol; 2021 Jul; 13(7):. PubMed ID: 34332502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded catalog of microbial genes and metagenome-assembled genomes from the pig gut microbiome.
    Chen C; Zhou Y; Fu H; Xiong X; Fang S; Jiang H; Wu J; Yang H; Gao J; Huang L
    Nat Commun; 2021 Feb; 12(1):1106. PubMed ID: 33597514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver disease.
    Scorletti E; Afolabi PR; Miles EA; Smith DE; Almehmadi A; Alshathry A; Moyses HE; Clough GF; Wright M; Patel J; Bindels L; Delzenne NM; Calder PC; Byrne CD
    Contemp Clin Trials; 2018 Aug; 71():113-123. PubMed ID: 29787859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome.
    Mayneris-Perxachs J; Cardellini M; Hoyles L; Latorre J; Davato F; Moreno-Navarrete JM; Arnoriaga-Rodríguez M; Serino M; Abbott J; Barton RH; Puig J; Fernández-Real X; Ricart W; Tomlinson C; Woodbridge M; Gentileschi P; Butcher SA; Holmes E; Nicholson JK; Pérez-Brocal V; Moya A; Clain DM; Burcelin R; Dumas ME; Federici M; Fernández-Real JM
    Microbiome; 2021 May; 9(1):104. PubMed ID: 33962692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases.
    Sharma SP; Suk KT; Kim DJ
    World J Gastroenterol; 2021 Oct; 27(37):6161-6179. PubMed ID: 34712025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nestlé moves into gut microbiome tests.
    Nat Biotechnol; 2017 Sep; 35(9):808. PubMed ID: 28898219
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of reduced metagenome and 16S rRNA gene sequencing for determination of genetic diversity and mother-child overlap of the gut associated microbiota.
    Ravi A; Avershina E; Angell IL; Ludvigsen J; Manohar P; Padmanaban S; Nachimuthu R; Snipen L; Rudi K
    J Microbiol Methods; 2018 Jun; 149():44-52. PubMed ID: 29501688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease.
    Vajro P; Paolella G; Fasano A
    J Pediatr Gastroenterol Nutr; 2013 May; 56(5):461-8. PubMed ID: 23287807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota and non-alcoholic fatty liver disease: new insights.
    Aron-Wisnewsky J; Gaborit B; Dutour A; Clement K
    Clin Microbiol Infect; 2013 Apr; 19(4):338-48. PubMed ID: 23452163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Integrated Metagenome Catalog Reveals New Insights into the Murine Gut Microbiome.
    Lesker TR; Durairaj AC; Gálvez EJC; Lagkouvardos I; Baines JF; Clavel T; Sczyrba A; McHardy AC; Strowig T
    Cell Rep; 2020 Mar; 30(9):2909-2922.e6. PubMed ID: 32130896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.
    Boursier J; Mueller O; Barret M; Machado M; Fizanne L; Araujo-Perez F; Guy CD; Seed PC; Rawls JF; David LA; Hunault G; Oberti F; Calès P; Diehl AM
    Hepatology; 2016 Mar; 63(3):764-75. PubMed ID: 26600078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.